Partnership insights
Collaborating, innovating, and finding new ways together to improve outcomes
Much more can be achieved when all players in the life sciences and pharmaceutical industries work together, in a truly collaborative way. At ICON, this means working in a way that goes beyond a traditional CRO. It means being a trusted partner.
Exploring partnership culture and its impact on outsourcing and operational strategy
Partnership culture within the clinical research industry has often been overlooked as a component of a successful outsourcing strategy. However, culture can support, inform, and maintain strategies and operational decision-making.
Webinar: Exploring partnership culture and its impact on outsourcing and operational strategy
In this webinar, Sanofi and ICON discuss how they created a shared partnership/alliance culture, which has evolved both the outsourcing strategy and operating model. Attendees will learn about the specific tools and methods used to develop and support the Sanofi / ICON partnership, including:
- Adaptation of the 9 Box Grid to assess cultural alignment and outsourcing and operational strategy, identifying areas of strength and opportunities for development
- An “ABCs of Culture” framework, designed to build cross-organisational cultural alignment.
The evolving relationship between sponsors and CROs
In this Q&A and accompanying podcast, Jeff James provides his perspectives on how CROs have matured to become true partners that offer expansive clinical trial and drug development services, and he spotlights ICON’s approach towards collaboration.
Sponsor and CRO pharmacovigilance and safety alliances
This whitepaper outlines the best practices and model options for ensuring success when outsourcing pharmacovigilance and patient safety services.
Rare disease registries: practical ways to build trust and collaboration with patient advocacy groups
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
Engaging physicians to support and increase clinical research activity
More and more healthcare institutions are looking to increase their research portfolio however engagement of busy physicians is always a challenge.
-
Media article: US Pharma and Biotech Summit 2024: Evolving clinical research
In this news article, Applied Clinical Trials reports on ICON CEO Steve Cutler’s discussion at the FT US Pharma and Biotech Summit.
-
Media article: Toward more intelligent collaboration: implementing data in partnerships
This article outlines how data can play a key role in supporting collaboration and achieving objectives, as strategic partnerships become more important in clinical resea
-
Media article: Biotech sector survey: From investment confidence to strategic collaborations
In this article from International Biopharmaceutical Industry, Chris Smyth, President of ICON Biotech outlines the findings of the recent ICON biotech sector survey, and explores the role of partnerships and the increasing trend of pharma collaboration, even at the pre-clinical stage.
-
Media article: Continued investment key to our success as a life sciences hotspot
Brendan Brennan, CFO, outlines how Ireland’s strong culture of partnership and collaboration has played an important part in the success of the life sciences industry.
-
.jpg?crop=yes&w=545&h=286&itok=BMbZOxVA "Boardroom Meeting (36)")
Media article: Shaking it up: The partnership paradigm in clinical research
Jeff James, Executive Vice President, Alliance Management, explores how outsourcing methodologies between large pharma and CROs have rapidly evolved across the industry.
-
Media article: Evolution in the outsourcing of clinical research
Partnership is an increasingly important criterium for bio/pharmaceutical sponsors as they seek more bespoke solutions and the flexibility of tailored outsourcing models.
-
Media article: Harmonising outsourcing to keep clinical trials on track
Debbie Gilmore, Vice President, outlines how strategic partnerships and approaches to outsourcing can be used to navigate a complex clinical research landscape.
-
Media article: The Pharma Letter Podcast: CRO sector surges in bio revolution
This episode of The Pharma Letter Podcast features an interview with ICON’s Chief Commercial Officer, George McMillan, who outlines how ICON is growing in size to take advantage of increasing demand for its services.
.jpg?crop=yes&w=2048&h=1077&a=0,145&itok=_NRSI_rY "Boardroom Meeting (36)"){kind=icon}
